Armin Kuellmer1, Tobias Mangold1, Dominik Bettinger1, Moritz Schiemer1, Julius Mueller1, Andreas Wannhoff2, Karel Caca2, Edris Wedi3, Tobias Kleemann4, Robert Thimme1, Arthur Schmidt5. 1. Department of Medicine II, Medical Center, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg, Germany. 2. Department of Internal Medicine and Gastroenterology, Hospital Ludwigsburg, Ludwigsburg, Germany. 3. Medizinische Klinik II / IV, Sana Klinikum Offenbach, Offenbach, Germany. 4. Medinische Klinik IV, Carl-Thiem-Klinikum Cottbus, Cottbus, Germany. 5. Department of Medicine II, Medical Center, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg, Germany. arthur.schmidt@uniklinik-freiburg.de.
Abstract
BACKGROUND: Surgery or transcatheter arterial embolization or are both considered as standard treatment of peptic ulcer bleeding (PUB) refractory to endoscopic hemostasis. Over-The-Scope clips (OTSC) have shown superiority to standard endoscopic treatment but a comparison with surgery has not been performed, yet. PATIENTS AND METHODS: In this retrospective, multicenter study, 103 patients treated with OTSC (n = 66) or surgery (n = 37) for refractory PUB in four tertiary care centers between 2009 and 2019 were analyzed. Primary endpoint was clinical success (successful hemostasis and no rebleeding within seven days). Secondary endpoints were adverse events, length of ICU-stay and in-hospital mortality. Univariable and multivariable regression models were performed to define predictive factors for allocation to surgical therapy and for mortality. RESULTS: Age, comorbidities, anticoagulation therapy, number of pretreatments, ulcer location, and Rockall-Score were similar in both groups. In the surgical group, there were significantly more patients in shock at rebleeding (78.1% vs. 43.9%; p = 0.002), larger ulcers (18.6 ± 7.4 mm vs. 23.0 ± 9.4 mm; p = 0.017) and more FIa bleedings (64.9% vs. 19.7%; p < 0.001) were detected. Clinical success was comparable (74.2% vs. 83.8%; p = 0.329). In the surgical group, length of ICU-stay (16.2 ± 18.0 days vs. 4.7 ± 6.6 days; p < 0.001), severe adverse events (70.3% vs. 4.5%; p < 0.001) and in-hospital mortality (35.1% vs. 9.1%; p = 0.003) were significantly higher. Multivariable analysis defined shock at rebleeding as the main predictor for allocation to surgical therapy (OR 4.063, 95%CI {1.496-11.033}, p = 0.006). Postsurgical adverse events were the main reason for the in-hospital mortality (OR 5.167, 95% CI {1.311-20.363}, p = 0.019). CONCLUSION: In this retrospective study, OTSC compared to surgical treatment showed comparable clinical success but was associated with shorter ICU-stay, less severe adverse events and lower in-hospital mortality.
BACKGROUND: Surgery or transcatheter arterial embolization or are both considered as standard treatment of peptic ulcer bleeding (PUB) refractory to endoscopic hemostasis. Over-The-Scope clips (OTSC) have shown superiority to standard endoscopic treatment but a comparison with surgery has not been performed, yet. PATIENTS AND METHODS: In this retrospective, multicenter study, 103 patients treated with OTSC (n = 66) or surgery (n = 37) for refractory PUB in four tertiary care centers between 2009 and 2019 were analyzed. Primary endpoint was clinical success (successful hemostasis and no rebleeding within seven days). Secondary endpoints were adverse events, length of ICU-stay and in-hospital mortality. Univariable and multivariable regression models were performed to define predictive factors for allocation to surgical therapy and for mortality. RESULTS: Age, comorbidities, anticoagulation therapy, number of pretreatments, ulcer location, and Rockall-Score were similar in both groups. In the surgical group, there were significantly more patients in shock at rebleeding (78.1% vs. 43.9%; p = 0.002), larger ulcers (18.6 ± 7.4 mm vs. 23.0 ± 9.4 mm; p = 0.017) and more FIa bleedings (64.9% vs. 19.7%; p < 0.001) were detected. Clinical success was comparable (74.2% vs. 83.8%; p = 0.329). In the surgical group, length of ICU-stay (16.2 ± 18.0 days vs. 4.7 ± 6.6 days; p < 0.001), severe adverse events (70.3% vs. 4.5%; p < 0.001) and in-hospital mortality (35.1% vs. 9.1%; p = 0.003) were significantly higher. Multivariable analysis defined shock at rebleeding as the main predictor for allocation to surgical therapy (OR 4.063, 95%CI {1.496-11.033}, p = 0.006). Postsurgical adverse events were the main reason for the in-hospital mortality (OR 5.167, 95% CI {1.311-20.363}, p = 0.019). CONCLUSION: In this retrospective study, OTSC compared to surgical treatment showed comparable clinical success but was associated with shorter ICU-stay, less severe adverse events and lower in-hospital mortality.
Authors: Ian M Gralnek; Adrian J Stanley; A John Morris; Marine Camus; James Lau; Angel Lanas; Stig B Laursen; Franco Radaelli; Ioannis S Papanikolaou; Tiago Cúrdia Gonçalves; Mario Dinis-Ribeiro; Halim Awadie; Georg Braun; Nicolette de Groot; Marianne Udd; Andres Sanchez-Yague; Ziv Neeman; Jeanin E van Hooft Journal: Endoscopy Date: 2021-02-10 Impact factor: 10.093
Authors: Arthur Schmidt; Stefan Gölder; Martin Goetz; Alexander Meining; James Lau; Stefan von Delius; Markus Escher; Arthur Hoffmann; Reiner Wiest; Helmut Messmann; Thomas Kratt; Benjamin Walter; Dominik Bettinger; Karel Caca Journal: Gastroenterology Date: 2018-05-24 Impact factor: 22.682
Authors: Emma Sverdén; Fredrik Mattsson; David Lindström; Anders Sondén; Yunxia Lu; Jesper Lagergren Journal: Ann Surg Date: 2019-02 Impact factor: 12.969
Authors: B Joseph Elmunzer; Scott D Young; John M Inadomi; Philip Schoenfeld; Loren Laine Journal: Am J Gastroenterol Date: 2008-08-05 Impact factor: 10.864